NEW YORK (GenomeWeb) – MBio Diagnostics, a developer of point-of-care diagnostic and sample testing technologies, announced on Thursday that it has closed a $6.3 million Series B round of financing.

The company said that the proceeds of the round will be used to refine its multiplex analyzer platform, which is based on proprietary planar waveguide and fluorescent detection technology, and make improvements to its manufacturing. The Boulder, Colorado-based firm said the system can detect a variety of analytes including proteins, cells, nucleic acids, and small molecules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.